{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:01:04Z","timestamp":1786636864936,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,27]]},"abstract":"<jats:p>Accurate assessment of ovarian reserve remains challenging in clinical practice, particularly when conventional markers like anti-m\u00fcllerian hormone (AMH) and antral follicle count show inconsistent results. Despite widespread use, AMH has limitations in predicting reproductive lifespan and oocyte quality. This study evaluated 2 emerging biomarkers, insulin-like peptide-3 (INSL3) and tumor necrosis factor receptor 2 (TNFR2), for ovarian reserve assessment. We included 179 women aged 20 to 40 years. Participants underwent ultrasound evaluation for antral follicle count and blood sampling for hormone measurements. Women were classified using decreased ovarian reserve (DOR) and premature ovarian insufficiency (POI) criteria. INSL3 showed moderate effectiveness in detecting both DOR (area under the curve [AUC]: 0.685) and POI (AUC: 0.711), though not as strong as AMH. TNFR2 was statistically significant in predicting DOR (AUC: 0.651) but ineffective for POI identification. While AMH remained the strongest marker, INSL3 may serve as a supportive indicator for evaluating ovarian reserve, especially in identifying women at risk of POI. TNFR2, despite its biological relevance, shows limited clinical usefulness. These findings indicate INSL3\u2019s potential as a complementary marker to improve individualized assessment of ovarian function.<\/jats:p>","DOI":"10.1097\/md.0000000000042842","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:00:25Z","timestamp":1751295625000},"page":"e42842","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the efficacy of potential ovarian reserve markers from theca and granulosa cells: INSL3 &amp; TNFR2"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0129-8710","authenticated-orcid":false,"given":"Asena","family":"Ayar Madenli","sequence":"first","affiliation":[{"name":"Department of Gynaecology of Obstetrics, Istinye University Faculty of Medicine, Istanbul, Turkiye"},{"name":"Department of Gynaecology and Obstetrics, Liv Hospital Vadistanbul, Istanbul, Turkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-2733","authenticated-orcid":false,"given":"Inci","family":"Oz","sequence":"additional","affiliation":[{"name":"Department of Gynaecology of Obstetrics, Medicana Atakoy Hospital, Istanbul, Turkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: a user\u2019s guide.","volume":"217","author":"Tal","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion.","volume":"114","author":"Penzias","year":"2020","journal-title":"Fertil Steril"},{"key":"R3-20260813","first-page":"411","article-title":"An update on ovarian aging and ovarian reserve tests.","volume":"9","author":"Amanvermez","year":"2016","journal-title":"Int J Fertil Steril"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10815-014-0257-5","article-title":"Genetic associations with diminished ovarian reserve: a systematic review of the literature.","volume":"31","author":"Greene","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"R5-20260813","doi-asserted-by":"crossref","first-page":"827678","DOI":"10.3389\/fphys.2022.827678","article-title":"Editorial: diminished ovarian reserve and poor ovarian response: diagnostic and therapeutic management.","volume":"13","author":"Annalisa","year":"2022","journal-title":"Front Physiol"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10815-015-0595-y","article-title":"Diminished ovarian reserve, premature ovarian failure, poor ovarian responder \u2013 a plea for universal definitions.","volume":"32","author":"Cohen","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE Guideline: management of women with premature ovarian insufficiency.","volume":"31","author":"Webber","year":"2016","journal-title":"Hum Reprod"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"hoae065","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency.","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum Reprod Open"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/GME.0000000000001424","article-title":"The menopause transition and women\u2019s health at midlife: a progress report from the Study of Women\u2019s Health Across the Nation (SWAN).","volume":"26","author":"El Khoudary","year":"2019","journal-title":"Menopause"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","article-title":"Evaluation of female fertility \u2013 AMH and ovarian reserve testing.","volume":"107","author":"Cedars","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-m\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function.","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"e19096","DOI":"10.2196\/19096","article-title":"An ovarian reserve assessment model based on anti-m\u00fcllerian hormone levels, follicle-stimulating hormone levels, and age: Retrospective cohort study.","volume":"22","author":"Xu","year":"2020","journal-title":"J Med Internet Res"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","article-title":"Anti-m\u00fcllerian hormone and folliculogenesis.","volume":"234","author":"Visser","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1093\/humrep\/det349","article-title":"Circulating insulin-like factor 3 (INSL3) in healthy and infertile women.","volume":"28","author":"Anand-Ivell","year":"2013","journal-title":"Hum Reprod"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/humupd\/dmy029","article-title":"Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology.","volume":"24","author":"Ivell","year":"2018","journal-title":"Hum Reprod Update"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.fertnstert.2020.08.005","article-title":"New theca-cell marker insulin-like factor 3 is associated with premature ovarian insufficiency.","volume":"115","author":"Zhu","year":"2021","journal-title":"Fertil Steril"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1095\/biolreprod.106.055509","article-title":"Tumor necrosis factor (TNF) receptor type 2 is an important mediator of TNF alpha function in the mouse ovary1.","volume":"76","author":"Greenfeld","year":"2007","journal-title":"Biol Reprod"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1095\/biolreprod.102.004820","article-title":"Changes in the expression of tumor necrosis factor (TNF) \u03b1, TNF\u03b1 receptor (TNFR) 2, and TNFR-associated factor 2 in granulosa cells during atresia in pig ovaries.","volume":"68","author":"Nakayama","year":"2003","journal-title":"Biol Reprod"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","article-title":"National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys.","volume":"9","author":"Mascarenhas","year":"2012","journal-title":"PLoS Med"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"R21-20260813","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/uog.18945","article-title":"Counting ovarian antral follicles by ultrasound: a practical guide.","volume":"51","author":"Coelho Neto","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R22-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","article-title":"Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.","volume":"54","author":"Diez\u2010Ruiz","year":"1995","journal-title":"Eur J Haematol"},{"key":"R23-20260813","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/diabetes.47.11.1757","article-title":"Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.","volume":"47","author":"Fern\u00e1ndez-Real","year":"1998","journal-title":"Diabetes"},{"key":"R24-20260813","article-title":"PASS 11.","author":"Hintze","year":"2011"},{"key":"R25-20260813","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.fertnstert.2015.05.017","article-title":"Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the society for assisted reproductive technology clinic outcomes reporting system.","volume":"104","author":"Devine","year":"2015","journal-title":"Fertil Steril"},{"key":"R26-20260813","doi-asserted-by":"crossref","first-page":"725473","DOI":"10.3389\/fcell.2021.725473","article-title":"The TNF-\u03b1\/TNFR2 pathway: targeting a brake to release the anti-tumor immune response.","volume":"9","author":"Moatti","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R27-20260813","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/GME.0000000000001162","article-title":"A prospective study of inflammatory biomarker levels and risk of early menopause.","volume":"26","author":"Bertone-Johnson","year":"2019","journal-title":"Menopause"},{"key":"R28-20260813","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1095\/biolreprod61.6.1616","article-title":"Alterations of events related to ovarian function in tumor necrosis factor receptor type I knockout mice1.","volume":"61","author":"Roby","year":"1999","journal-title":"Biol Reprod"},{"key":"R29-20260813","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-019-0464-0","article-title":"Antral follicle count (AFC) and serum anti-M\u00fcllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.","volume":"17","author":"Khan","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"R30-20260813","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mefs.2015.08.005","article-title":"The value of different ovarian reserve tests in the prediction of ovarian response in patients with unexplained infertility.","volume":"21","author":"Islam","year":"2016","journal-title":"Middle East Fertility Soc J"},{"key":"R31-20260813","doi-asserted-by":"crossref","first-page":"601752","DOI":"10.3389\/fendo.2021.601752","article-title":"Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies.","volume":"12","author":"Jiao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:02:00Z","timestamp":1786633320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000042842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":31,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042842","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}